The Department of Health and Human Services completed its review of rescheduling cannabis and sent a recommendation to the Drug Enforcement Administration, the agencies confirmed.
Bloomberg News reported that HHS recommended demoting the drug from Schedule I to Schedule III, but neither agency would confirm details. The recommendation is nonbinding, and the DEA will make the final decision.
“We can confirm DEA received a letter from the Department of Health and Human Services providing its findings and recommendation on marijuana scheduling, pursuant to President Biden’s request for a review,” the DEA said in a statement.
